However, the relationship between protein-bound uremic toxins and Fibroblast growth factor-23 (FGF23) has not been studied before. Our objective was to explore the association of IS and PCS with FGF23 in a CKD-based cohort. Methods: This is a cross-sectional study enrolled 80 stable CKD stage 3–5 patients who met the inclusion criteria in a single medical center. Serum levels of IS, PCS and FGF23 were measured concurrently. General biochemistry and patient background were also investigated. Results: Serum FGF23 and IS concentrations were elevated commensurately with deteriorating renal function. Pearson’s analysis showed that FGF23 levels was significantly associated with BUN (r = 0.381,

p < 0.05), creatinine (r = 0.632, p < 0.01), estimated GFR (r = −0.447, p < 0.05), Phosphate (r = 0.543, p < 0.01), intact-PTH (r = 0.543, p < 0.01), IS (r = 0.432, p < 0.01) and PCS (r = 0.318, p < 0.05). MDV3100 After adjusting other confounding factors by stepwise Abiraterone multiple linear regression analysis, only creatinine (β = 0.82, p < 0.01), phosphate (β = 0.28, p = 0.02) and IS (β = 0.39, p = 0.04) retained statistically significant associations with FGF23. Moreover, serum levels of IS was higher in patients with high FGF23 concentration (>90 pg/ml, median value) than those with lower FGF23 (p < 0.01). Conclusion: Our results indicated that only IS but not PCS correlated independently with FGF23 in worsening CKD. IS may be an independent factor

involved in regulation of bone-mineral Demeclocycline metabolism. INOUE AKIKO, KITAMURA SHINJI, TSUJI KENJI, MAKINO HIROFUMI Okayama Univeisity Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Introduction: Semaphorin3a

is reported as a secreted protein which has various roles in neural axon guidance, vascular patterning, immune regulation and cancer progression. Regarding to kidney, semaphoin3a is reported to express in the glomerular podocyte, distal tubule and collecting tubule and it makes an important role to regulate podocyte and endothelial cell differentiation. However, there are few report that semsphorin3a is related to kidney disease on bedside. Here, we report that semaphorin3a has the relevance to nephrotic syndrome and other nephropathies. Methods: In this retrospective study, we admitted patients that entered for renal biopsy to our hospital to establish the diagnosis of kidney disease. We made a diagnosis of each nephropathy by the histological findings of renal biopsy and clinical findings. Before sampling, written Informed consent was obtained from each patient. We collected the urine and blood samples from these patients, and evaluated Urinary Semaphorin3a and nephrin level by using ELISA method. After the diagnosis, we divided these patients into 4 groups (minor change nephrotic syndrome (MCNS) (n = 7), IgA nephritis (IgA-N) (n = 13), membranous nephropathy (MN) (n = 8) and thin basement membrane disease (TBM) (n = 4)), we evaluated the relevance to proteinuria.